Fierz W
Institue for Clinical Microbiology and Immunology, St. Gallen, Switzerland.
Methods Mol Med. 1998;13:443-71. doi: 10.1385/0-89603-485-2:443.
Serological testing and the use of immunochemical techniques are well established in the clinical laboratory and then uses are still rapidly increasing. Serological tests are applied for the diagnosis of infectious diseases, autoimmune disorders, allergies, and malignancies. Yet despite their widespread use, immunoassays are inflicted with a number of significant problems that lead to a substantial variation in reliability and accuracy of currently available tests. In the recent process of establishing procedures and criteria for quality assurance in the clinical laboratory an increased awareness of these problems has arisen among the clinical and reference laboratories as well as among the manufacturers of commercial test kits. The recognition of this situation prompted the US National Committee for Clinical Laboratory Standards (NCCLS) to create specific guidelines that address "the generrc problems of preparation and characterization of antigens and antibodies, testing using these reagents, and understanding the results" These guidelines are made public in the NCCLS document I/LA 18-A Specifications for Immunological Testing for Infectious Diseases; Approved Guideline, issued in December 1994 (1). References to this document will be made in this chapter where appropriate, and particularly, attempts will be made to adhere to the definitions of terms and procedures as they are laid down in the NCCLS consensus document.
血清学检测和免疫化学技术的应用在临床实验室中已得到充分确立,并且其应用仍在迅速增加。血清学检测可用于诊断传染病、自身免疫性疾病、过敏和恶性肿瘤。然而,尽管免疫测定法被广泛使用,但它存在许多重大问题,导致目前可用检测的可靠性和准确性存在很大差异。在临床实验室最近建立质量保证程序和标准的过程中,临床实验室、参考实验室以及商业检测试剂盒制造商对这些问题的认识有所提高。认识到这种情况促使美国国家临床实验室标准委员会(NCCLS)制定了具体指南,以解决“抗原和抗体的制备与特性鉴定、使用这些试剂进行检测以及理解检测结果等一般问题”。这些指南在NCCLS于1994年12月发布的文件I/LA 18-A《传染病免疫检测规范;批准指南》中公布(1)。本章将在适当之处引用该文件,特别是将尝试遵循NCCLS共识文件中规定的术语和程序定义。